U.S. Organ On A Chip Market Size & Outlook, 2024-2030

The organ on a chip market in the United States is expected to reach a projected revenue of US$ 510.3 million by 2030. A compound annual growth rate of 38.3% is expected of the United States organ on a chip market from 2025 to 2030.
Revenue, 2024 (US$M)
$73.6
Forecast, 2030 (US$M)
$510.3
CAGR, 2025 - 2030
38.3%
Report Coverage
U.S.

U.S. organ on a chip market highlights

  • The U.S. organ on a chip market generated a revenue of USD 53.8 million in 2023 and is expected to reach USD 510.3 million by 2030.
  • The U.S. market is expected to grow at a CAGR of 37.9% from 2024 to 2030.
  • In terms of segment, services was the largest revenue generating product & service in 2023.
  • Product is the most lucrative product & service segment registering the fastest growth during the forecast period.


Organ on a chip market data book summary

Market revenue in 2023USD 53.8 million
Market revenue in 2030USD 510.3 million
Growth rate37.9% (CAGR from 2023 to 2030)
Largest segmentServices
Fastest growing segmentProduct
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationServices, Product
Key market players worldwideEmulate, Mimetas, Valo Health, Nortis, AxoSim, BICO, CN Bio, SynVivo, Draper, AlveoliX AG


Other key industry trends

  • In terms of revenue, U.S. accounted for 45.9% of the global organ on a chip market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. organ on a chip market is projected to lead the regional market in terms of revenue in 2030.
  • U.S. is the fastest growing regional market in North America and is projected to reach USD 510.3 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Organ On A Chip Market Companies

Name Profile # Employees HQ Website

U.S. organ on a chip market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to organ on a chip market will help companies and investors design strategic landscapes.


Services was the largest segment with a revenue share of 52.42% in 2024. Horizon Databook has segmented the U.S. organ on a chip market based on services, product covering the revenue growth of each sub-segment from 2018 to 2030.


The U.S. OOC market is growing rapidly, driven by advances in biomedical research and an increasing need for better drug testing methods. 

OOC technology uses microchips to mimic the functions of human organs, providing a more accurate way to study diseases and test new drugs compared to traditional animal testing. 

Key drivers for the U.S. market include strong government funding, a well-established pharmaceutical industry, and high demand for cutting-edge drug development technologies. 

This approach is gaining traction among pharmaceutical and biotech companies as it enhances the efficiency and ethics of drug development.

Reasons to subscribe to U.S. organ on a chip market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of U.S. organ on a chip market databook

  • Our clientele includes a mix of organ on a chip market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the U.S. organ on a chip market, including forecasts for subscribers. This country databook contains high-level insights into U.S. organ on a chip market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

U.S. organ on a chip market report size, by product & service, 2018-2030 (US$M)

U.S. Organ On A Chip Market Share, 2024 & 2030 (US$M)

U.S. organ on a chip market report size, by product & service, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more